Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 5, 2007, Pages 505-512

  Varella Garcia, Marileila ^a   Chen, Lin ^a   Powell, Roger L ^a   Hirsch, Fred R ^a   Kennedy, Timothy C ^b   Keith, Robert ^a,c   Miller, York E ^a,c   Mitchell, John D ^a   Franklin, Wilbur A ^a,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

FISH; Lung cancer; Premalignant conditions; Spectral karyotype

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; BRONCHIOLE; BRONCHUS BIOPSY; CANCER PATIENT; CELL CULTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DAMAGE; CHROMOSOME TRANSLOCATION; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METAPHASE; PRIORITY JOURNAL; SPECTRAL KARYOTYPING;

ADULT; AGED; AGED, 80 AND OVER; BRONCHI; CASE-CONTROL STUDIES; CELLS, CULTURED; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RESPIRATORY MUCOSA; RISK; SENSITIVITY AND SPECIFICITY; SMOKING; SPECTRAL KARYOTYPING; TUMOR MARKERS, BIOLOGICAL;

EID: 34548456963     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200609-1329OC     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol 2005;23:3175-3185.
3. Shields PG. Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst 2002;94:1435-1444.
4. Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou JY, Taguchi T, Keller SM. Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosomes Cancer 1994;11:178-194.
5. Miura I, Graziano SL, Cheng JQ, Doyle LA, Testa JR. Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. Cancer Res 1992;52:1322-1328.
6. Haruki N, Harano T, Masuda A, Kiyono T, Takahashi T, Tatematsu Y, Shimizu S, Mitsudomi T, Konishi H, Osada H, et al. Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am J Pathol 2001;159:1345-1352.
7. Crowell RE, Gilliland FD, Temes RT, Harms HJ, Neft RE, Heaphy E, Auckley DH, Crooks LA, Jordan SW, Samet JM, et al. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer. Cancer Epidemiol Biomarkers Prev 1996;5:631-637.
8. Zojer N, Dekan G, Ackermann J, Fiegl M, Kaufmann H, Drach J, Huber H. Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation. Lung Cancer 2000;28:225-235.
9. Romeo MS, Sokolova IA, Morrison LE, Zeng C, Baron AE, Hirsch FR, Miller YE, Franklin WA, Varella-Garcia M. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn 2003;5:103-112.
10. Lechner JF, Haugen A, Autrup H, McClendon IA, Trump BF, Harris CC. Clonal growth of epithelial cells from normal adult human bronchus. Cancer Res 1981;41:2294-2304.
11. Franklin WA, Folkvord JM, Varella-Garcia M, Kennedy T, Proudfoot S, Cook R, Dempsey EC, Helm K, Bunn PA, Miller YE. Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites. Am J Respir Cell Mol Biol 1996;15:297-304.
12. Sozzi G, Miozzo M, Tagliabue E, Calderone C, Lombardi L, Pilotti S, Pastorino U, Pierotti MA, Della Porta G. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 1991;51:400-404.
13. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, De Gregorio L, Manenti G, Radice P, Minoletti F, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995;55:135-140.
14. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Della Porta G, Pierotti MA. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992;52:6079-6082.
15. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-497.
16. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 2001;125:87-99.
17. Franklin WA, Wistuba II, Geisinger K, Lam S, Hirsch F, Muller KM, Sozzi G, Brambilla E, Gazdar A. Squamous dysplasia and carcinoma in situ. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. Pathology and Genetics of Tumours of Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004. pp. 68-72.
18. Shaffer LG, Tommerup N, editors. ISCN 2005: An International System for Human Cytogenetic Nomenclature (2005). Basel, Switzerland: S. Karger AG; 2005.
19. Varella-Garcia M, Gemmill RM, Rabenhorst SH, Lotto A, Drabkin HA, Archer PA, Franklin WA. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res 1998;58:4701-4707.
20. Bunn PA Jr, Helfrich B, Soriano AF, Franklin WA, Varella-Garcia M, Hirsch FR, Baron A, Zeng C, Chan DC. Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin Cancer Res 2001;7:3239-3250.
21. Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A, Bunn PA Jr. Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer 2002;86:1449-1456.
22. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, et al. Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 1996;14:312-315.
23. Grigorova M, Lyman RC, Caldas C, Edwards PA. Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping. Cancer Genet Cytogenet 2005;162:1-9.
24. Sy SM, Fan B, Lee TW, Mok TS, Pang E, Yim A, Wong N. Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers. Cancer Genet Cytogenet 2004;153:57-59.
25. Sy SM, Wong N, Lee TW, Tse G, Mok TS, Fan B, Pang E, Johnson PJ, Yim A. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer 2004;40:1082-1094.
26. Sirotkin K, Gobu V, Knaus R, Plotkin J, Shenmen C, Ostell J, Khotomliansky L, Groesbeck T, Knutsen T, Padilla-Nash H, et al. SKY/M-FISH & CGH Database. [Internet] 2007 [accessed 2007 Jun 21]. Available from: http://www.ncbi.nlm.nih.gov/sky/
27. Boveri T. The origin of malignant tumors [English translation of original German text - Jena, Germany: Gustav Fischer; 1914]. Baltimore: Williams and Wilkins; 1929.
28. Choma D, Daures JP, Quantin X, Pujol JL. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer 2001;85:14-22.
29. Hirano T, Franzen B, Kato H, Ebihara Y, Auer G. Genesis of squamous cell lung carcinoma: sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol 1994;144:296-302.
30. Neft RE, Crowell RE, Gilliland FD, Murphy MM, Lane JL, Harms H, Coons T, Heaphy E, Belinsky SA, Lechner JF. Frequency of trisomy 20 in nonmalignant bronchial epithelium from lung cancer patients and cancer-free former uranium miners and smokers. Cancer Epidemiol Biomarkers Prev 1998;7:1051-1054.
31. Lechner JF, Neft RE, Gilliland FD, Crowell RE, Auckley DH, Temes RT, Belinsky SA. Individuals at high risk for lung cancer have airway epithelial cells with chromosome aberrations frequently found in lung tumor cells. In Vivo 1998;12:23-26.
32. Ai H, Barrera JE, Pan Z, Meyers AD, Varella-Garcia M. Identification of individuals at high risk for head and neck carcinogenesis using chromosome aneuploidy detected by fluorescence in situ hybridization. Mutat Res 1999;439:223-232.
33. Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, Hirsch FR, Byers T, Kennedy T, Miller YE, et al. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev 2004;28:244-251.
34. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM, Miller YE. Widely dispersed p53 mutation in respiratory epithelium: a novel mechanism for field carcinogenesis. J Clin Invest 1997;100:2133-2137.
35. Hittelman WN. Genetic instability in epithelial tissues at risk for cancer. Ann N Y Acad Sci 2001;952:1-12.
36. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-6